Texas Medical Center President and CEO William “Bill” McKeon highlighted TMC’s biggest accomplishments in a downtown Houston speech Thursday and previewed major projects planned for 2019, including the groundbreaking of its TMC3 research hub.
McKeon’s remarks came at the State of the Texas Medical Center, hosted by the Greater Houston Partnership at the Hilton Americas.
The planned TMC3 biomedical research hub will cluster researchers and industry experts together on a collaborative 30-acre campus off of Bertner Avenue, between Old Spanish Trail and Braeswood Boulevard.
TMC is partnering with four of its members — Baylor College of Medicine, Texas A&M University Health Science Center, The University of Texas Health Science Center and The University of Texas M.D. Anderson Cancer Center — on the project. The campus will integrate leading researchers with top-tier expertise from the private sector.
“It’s what I think will be the most exciting, activated area of the medical city in the future,” McKeon said.
In addition to research space and labs, the project will contain office buildings, retail and restaurant space, a hotel and conference center and an iconic rooftop park. The rooftop park will take the iconic double helix shape of a DNA strand and is being designed by famed landscape architect James Corner, who designed New York’s High Line, among other world-famous projects.
The park, McKeon said, is especially important now, as cities across the country increasingly see the value of green space.
“I think it’s going to be a differentiator of our city for the next 50 years,” McKeon said of the Helix Park. “The way you compete with Boston and San Francisco is by (increasing) density and taking advantage of this green space.”
In his remarks, McKeon also highlighted new TMC partnerships with Australia and the United Kingdom, known as BioBridges, that will foster collaboration between researchers in each of those countries and TMC, with the goal of accelerating discovery that will lead to life-saving treatments.
Bob Harvey, president and CEO of the Greater Houston Partnership, touted TMC’s international success as well.
“When I travel the world, my calling card is the Texas Medical Center, because that’s what they think of when they think of Houston,” Harvey said.
McKeon discussed the role TMC has played in fostering the development of medical startups in Houston. He said TMC’s new Venture Fund has invested $2.5 million in early-stage companies, providing them with the vital capital they need to grow. Profits from those investments will be directed back into the Venture Fund so that TMC can continue to support other companies.
He also spoke about the work of TMC’s Clinical Research Institute, which developed a common Institutional Review Board (IRB) that can be used across TMC members, increasing the speed at which clinical trials can be launched and conducted. The effort eliminates the redundancy that researchers face when they must seek approval to conduct trials at multiple institutions.
McKeon touted the nearly two dozen medical device companies that just completed their time in the TMCx accelerator, culminating in this week’s Demo Day event at the TMC Innovation Institute. The 23 companies that just graduated from the program have signed a total of 101 agreements with TMC members in just a few months.
“There’s no place else in the world you can do that,” he said.
RT @McGovernMed: Dr. John Higgins weighs in on the new physical activity guidelines encourage movement ‘anytime, anywhere’ https://t.co/Z7v…
WVU holds grand opening for Veteran and Military Family Support Headquarters https://t.co/7wtsurK2Za
RT @UHoustonLib: UH Libraries invites @UHouston faculty and students to submit an application for the Digital Scholarship Spring Institute…
@CharlesManick @uhdowntown the architecture & law libraries are usually pretty quiet!
RT @UHFoodie: Hey Coogs, wondering what's open this week? You can always check to see what's open on the Dine On Campus mobile app! Or visi…
Here at Baylor College of Medicine, we are more than just healthcare. See how our students, trainees, faculty and staff help support our local and global community. https://t.co/QAAoAGCyYz #community https://t.co/6ZYlVFRwEJ
MD Anderson Cancer Center@MDAndersonNews
Our @wwierda weighs in on two #CLL case studies in this interview with @TargetedOnc: https://t.co/SP4sGJ8eOW #leusm #endcancer
Anticoagulants reduce your risk for heart attack, stroke, and blockages in your arteries and veins by preventing blood clots from forming and growing. https://t.co/DRXnsvUDEg
Dartmouth study finds VA hospitals outperform others in same regions https://t.co/OG5vDccse5
RT @GuillotWright: “It’s about the money.” Great information about health inequity at UTMB’s Health Policy Dialogue. Thanks @utmbhealth and…
MD Anderson Cancer Center@MDAndersonNews
Our MD Anderson Cancer Network is helping #endcancer across the nation and beyond. Our @mekupferman explains: https://t.co/WJexdp17fQ #endcancer
TAMU Health Sciences@TAMHSC
“I knew I wanted to conduct research that involved health outcomes in children,” Preston said. “I was a teacher; I know kids can’t advocate for themselves.” https://t.co/eJUkBWMSVM@TAMU_SPH #TAMHSC #AggieHealth #TAMUHealth #TAMU https://t.co/lI9E7K0x5J
RT @medical_xpress: An integrated approach to finding new treatments for #breastcancer @BCMHouston @PNASNews https://t.co/9wNFmE6hti
‘Tis the season to be safe! We're sharing ways to keep your family safe this holiday season: https://t.co/rXeKCboGdy #texaschildrens
RT @BCMHouston_News: .@bcmhouston @BCMEthics's Dr. Andrew Childress takes a deep look into Mary Shelley's "Frankenstein" to discover what w…